Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma

INTRODUCTION: Nivolumab is effective for advanced renal cell carcinoma; however, reports are limited wherein nivolumab is combined with sequential therapy of angiogenesis inhibitors and metastasectomy. CASE PRESENTATION: A 65‐year‐old man was diagnosed with left renal cell carcinoma of cT2aN0M1 with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagimoto, Hiroki, Kashima, Soki, Doi, Kazuki, Nakayama, Shintaro, Sano, Takanori, Imai, Satoshi, Yasufuku, Tomihiko, Muramaki, Mototsugu, Yamada, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609183/
https://www.ncbi.nlm.nih.gov/pubmed/33163928
http://dx.doi.org/10.1002/iju5.12220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609183/
https://www.ncbi.nlm.nih.gov/pubmed/33163928
http://dx.doi.org/10.1002/iju5.12220

Ejemplares similares